MENU

JANX Janux Therapeutics Forecast, Technical & Fundamental Analysis

Janux Therapeutics Inc is a clinical-stage biopharmaceutical company developing tumor-activated immunotherapies for cancer... Show more

JANX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
View a ticker or compare two or three
JANX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

JANX is expected to report earnings to rise 28.57% to -44 cents per share on November 05

Janux Therapeutics JANX Stock Earnings Reports
Q3'26
Est.
$-0.45
Q2'26
Missed
by $0.08
Q1'26
Beat
by $0.18
Q4'25
Beat
by $0.11
Q3'25
Beat
by $0.23
The last earnings report on August 06 showed earnings per share of -34 cents, missing the estimate of -27 cents. With 287.43K shares outstanding, the current market capitalization sits at 1.04B.
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ESAB66.361.17
+1.79%
ESAB Corp
WHG18.70-0.04
-0.21%
Westwood Holdings Group
ALC67.43-0.40
-0.59%
Alcon
RKTO0.53-0.01
-1.11%
Rocket One Inc.
VSTM9.21-0.13
-1.39%
Verastem

JANX and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, JANX has been loosely correlated with VIR. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if JANX jumps, then VIR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To JANX
1D Price
Change %
JANX100%
-1.57%
VIR - JANX
38%
Loosely correlated
-1.58%
ORMP - JANX
36%
Loosely correlated
-0.24%
VTGN - JANX
36%
Loosely correlated
-2.12%
URGN - JANX
36%
Loosely correlated
+1.34%
ELTX - JANX
34%
Loosely correlated
+6.37%
More
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Industry
N/A
Address
10955 Vista Sorrento Parkway
Phone
+1 858 751-4493
Employees
109
Web
https://www.januxrx.com
Janux Therapeutics (JANX) stock Forecast, Price Targets and Analysts Predictions - Tickeron.com